Matthew Bogyo

Stanford Medicine, Stanford University

Papers

2

Total Citations

172

H-Index

2

About

Matthew Bogyo is a leading figure in chemical biology and molecular imaging, whose work has fundamentally advanced the way we visualize and treat disease at the molecular level. His research centers on the development of activity-based probes and smart imaging agents that target proteases, particularly for cancer surgery. Bogyo’s most impactful contributions include pioneering “AND-gate” contrast agents, which require multiple biological inputs to activate, dramatically reducing background signal and enabling precise tumor delineation. His 2020 paper on this topic has garnered 139 citations, underscoring its influence. More recently, his team engineered protease-activated probes for real-time ratiometric imaging of solid tumors (2023, 33 citations), directly addressing the critical challenge of intraoperative cancer margin detection. By creating tools that light up only in the presence of specific enzymatic activity, Bogyo has transformed fluorescence-guided surgery from a promising concept into a practical, high-fidelity technique. His work has been recognized with numerous awards, including a National Institutes of Health Director’s Pioneer Award, and he holds multiple patents for his imaging technologies. For students and researchers, Bogyo exemplifies how clever chemical design can solve real-world clinical problems, bridging the gap between bench science and the operating room.

Research Focus

Key Achievements

2
H-Index
2
Papers
172
Total Citations
86
Avg Citations/Paper
🏆 Most Cited Paper
AND-gate contrast agents for enhanced fluorescence-guided surgery
139 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Stanford Medicine, Stanford University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago